Statements (32)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
oral contraceptive
|
| gptkbp:activeIngredient |
gptkb:ethinyl_estradiol
desogestrel |
| gptkbp:alternativeTo |
gptkb:Apri
gptkb:Desogen Ortho-Cept |
| gptkbp:approvedBy |
gptkb:FDA
1998 |
| gptkbp:ATCCode |
G03AA09
|
| gptkbp:broadcastOn |
prescription only
|
| gptkbp:cause |
nausea
headache breast tenderness irregular bleeding |
| gptkbp:containsInactiveIngredient |
ethinyl estradiol (in placebo pills)
|
| gptkbp:contraindication |
gptkb:liver_disease
pregnancy history of thromboembolic disorders uncontrolled hypertension known or suspected breast cancer |
| gptkbp:form |
gptkb:tablet
|
| gptkbp:genericName |
desogestrel and ethinyl estradiol tablets
|
| gptkbp:hasInactivePill |
yes
|
| https://www.w3.org/2000/01/rdf-schema#label |
Mircette
|
| gptkbp:marketedAs |
gptkb:Teva_Pharmaceuticals
|
| gptkbp:prevention |
pregnancy
|
| gptkbp:regulates |
menstrual cycle
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:type |
28 tablets
|
| gptkbp:usedFor |
birth control
|
| gptkbp:bfsParent |
gptkb:ethinyl_estradiol
|
| gptkbp:bfsLayer |
7
|